Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ubiquitin E3 ligase MID1 inhibits the innate immune response by ubiquitinating IRF3.
Chen X, Xu Y, Tu W, Huang F, Zuo Y, Zhang HG, Jin L, Feng Q, Ren T, He J, Miao Y, Yuan Y, Zhao Q, Liu J, Zhang R, Zhu L, Qian F, Zhu C, Zheng H, Wang J. Chen X, et al. Among authors: zhang r, zhang hg. Immunology. 2021 Jul;163(3):278-292. doi: 10.1111/imm.13315. Epub 2021 Feb 22. Immunology. 2021. PMID: 33513265 Free PMC article.
E3 ubiquitin ligase MID1 ubiquitinates and degrades type-I interferon receptor 2.
Chen X, Zhao Q, Xu Y, Wu Q, Zhang R, Du Q, Miao Y, Zuo Y, Zhang HG, Huang F, Ren T, He J, Qiao C, Li Y, Li S, Xu Y, Wu D, Yu Z, Lv H, Wang J, Zheng H, Yuan Y. Chen X, et al. Among authors: zhang r, zhang hg. Immunology. 2022 Nov;167(3):398-412. doi: 10.1111/imm.13544. Epub 2022 Jul 23. Immunology. 2022. PMID: 35794827 Free article.
Immune checkpoint inhibitors: breakthroughs in cancer treatment.
Kong X, Zhang J, Chen S, Wang X, Xi Q, Shen H, Zhang R. Kong X, et al. Among authors: zhang r. Cancer Biol Med. 2024 May 24:j.issn.2095-3941.2024.0055. doi: 10.20892/j.issn.2095-3941.2024.0055. Online ahead of print. Cancer Biol Med. 2024. PMID: 38801082 Review.
34,552 results
You have reached the last available page of results. Please see the User Guide for more information.